Who
Richard Alan Rudick
Director
Company insider
Files Form 4 as: Director, Immunic.
In numbers
- Trades disclosed
- 10
- Buys
- 2
- Sells
- 0
- Bought
- $201K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 26 Apr 2023
- Last trade
- 5 Jul 2026
- Last filed
- 7 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jul 2026filed 7 Jul 2026 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,370 at $0.00 | filing |
| 5 Jul 2026filed 7 Jul 2026 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,370 at $0.00 | filing |
| 29 Jun 2026filed 29 Jun 2026 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,370 at $0.00 | filing |
| 29 Jun 2026filed 29 Jun 2026 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,370 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 3 Jun 2025filed 4 Jun 2025 | IMUX ImmunicBiotechnology | SEC FORM 4 Bought | $100K143,075 at $0.70 | filing |
| 12 Nov 2024filed 13 Nov 2024 | IMUX ImmunicBiotechnology | SEC FORM 4 Bought | $100K87,300 at $1.15 | filing |
| 11 Jun 2024filed 12 Jun 2024 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 28 Jun 2023filed 29 Jun 2023 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 26 Apr 2023filed 27 Apr 2023 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.